EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age

Sedigheh Ekraminasab, Mahmood Noorishadkam, Hossein Neamatzadeh, Mohamad Hosein Lookzadeh, Seyed Reza Mirjalili, Mahta Mazaheri, Seyedeh Elham Shams

Frontiers in Pediatrics · 24.04.2025 · 13

DOI: 10.3389/fped.2025.1518957 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 24.04.2025. Verfasst von Sedigheh Ekraminasab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Budesonide, an inhaled corticosteroid, and surfactant, a substance that lowers surface tension in the lungs, are both used to prevent Bronchopulmonary Dysplasia (BPD). This meta-analysis evaluates the effectiveness of combining budesonide and surfactant in preventing BPD in preterm neonates compared to surfactant alone.

Method

A comprehensive search of electronic databases, including PubMed, Scopus, Google Scholar, CNKI, and Embase, was conducted from their inception up to August 30, 2024. The focus was on evaluating the combination of Budesonide and surfactant for the prevention of BPD in preterm neonates. This assessment involved calculating ORs and their 95% CIs to determine the treatment's effectiveness. The primary outcomes measured were the incidence of BPD and mortality rates, while secondary outcomes included the rates of intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), patent ductus arteriosus (PDA), sepsis, neonatal necrotizing enterocolitis (NEC), and pneumothorax.

Results

This research, combining a meta-analysis and observational data, indicates that Budesonide-Surfactant therapy significantly reduces BPD in preterm neonates with NRDS, regardless of gestational age. Additional benefits, including decreased mortality (in ≥27 gestational weeks), NEC, PDA, ROP, and Sepsis, were observed in the observational study, though pneumothorax increased in the ≥27 gestational weeks group. The meta-analysis corroborated reductions in BPD, PDA, and mortality (in ≥27 gestational weeks), supporting the potential of Budesonide-Surfactant to improve outcomes in preterm infants.

Conclusions

The intratracheal administration of pulmonary surfactants combined with budesonide was associated with a reduction in the incidence of BPD, mortality, and PDA. Although the prevalence of ROP, NEC, IVH, and sepsis was lower in the test group compared to the control group, these differences did not reach statistical significance. These findings suggest that the combined use of budesonide and surfactant is effective in preventing BPD and mortality, as well as in reducing certain secondary outcomes.

Schlagwörter

Stichwörter der Autor:innen

bronchopulmonary dysplasiabudesonidecontrolled trialspreterm neonatespulmonary surfactant

Autor:innen und Institutionen

  • Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Pediatrics, Hamadan University of Medical Sciences, Hamadan, Iran.

Zitieren

APA

Ekraminasab, S., Noorishadkam, M., Neamatzadeh, H., Lookzadeh, M. H., Mirjalili, S. R., Mazaheri, M., & Shams, S. E. (2025). Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age. Frontiers in Pediatrics, 13. https://doi.org/10.3389/fped.2025.1518957

Vancouver

Ekraminasab S, Noorishadkam M, Neamatzadeh H, Lookzadeh MH, Mirjalili SR, Mazaheri M, et al. Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age. Frontiers in Pediatrics. 2025;13. doi:10.3389/fped.2025.1518957

BibTeX
@article{Ekraminasab2025,
  author = {Ekraminasab, Sedigheh and Noorishadkam, Mahmood and Neamatzadeh, Hossein and Lookzadeh, Mohamad Hosein and Mirjalili, Seyed Reza and Mazaheri, Mahta and Shams, Seyedeh Elham},
  title = {Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age},
  journal = {Frontiers in Pediatrics},
  year = {2025},
  volume = {13},
  doi = {10.3389/fped.2025.1518957}
}
Kostenlos starten →